Testing effectiveness (Phase 2)Study completedNCT02096666What this trial is testingA Phase 1/2 Study Evaluating AMG 337 in Asian SubjectsWho this might be right forStomach Neoplasms Amgen 11
Testing effectiveness (Phase 2)Study completedNCT01364493What this trial is testingEvaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerWho this might be right forGastric Cancer Peking University 51
Early research (Phase 1)Study completedNCT00291473What this trial is testingSafety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing CancersWho this might be right forEsophageal CancerLung CancerStomach Cancer+2 more Ludwig Institute for Cancer Research 9
Not applicableLooking for participantsNCT06649474What this trial is testingEvaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1Who this might be right forPancreatic CancerResectable Pancreatic AdenocarcinomaAdenocarcinoma+3 more University Hospital, Clermont-Ferrand 100
Early research (Phase 1)Study completedNCT00909402What this trial is testingBMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal AdenocarcinomasWho this might be right forStomach NeoplasmsEsophageal Neoplasms Bristol-Myers Squibb 39
Not applicableLooking for participantsNCT07675967What this trial is testingClonal Hematopoiesis Chemotherapy and Radiation Effects StudyWho this might be right forLung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more Dana-Farber Cancer Institute 5,000
Large-scale testing (Phase 3)Study completedNCT03042611What this trial is testingEvaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric CancerWho this might be right forGastric CancerGastric Adenocarcinoma Elevar Therapeutics 460
Early research (Phase 1)Looking for participantsNCT06657144What this trial is testingCHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Coherus Oncology, Inc. 154
Testing effectiveness (Phase 2)Looking for participantsNCT04114136What this trial is testingAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesWho this might be right forMelanomaNSCLCHepatocellular Carcinoma+5 more Dan Zandberg 72
Large-scale testing (Phase 3)Looking for participantsNCT07221149What this trial is testingEvaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)Who this might be right forUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Bristol-Myers Squibb 690
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Large-scale testing (Phase 3)Active Not RecruitingNCT05152147What this trial is testingZanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersWho this might be right forGastric NeoplasmsGastroesophageal AdenocarcinomaEsophageal Adenocarcinoma Jazz Pharmaceuticals 920
Testing effectiveness (Phase 2)Study completedNCT03469557What this trial is testingBGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma BeiGene 30
Testing effectiveness (Phase 2)WithdrawnNCT04464967What this trial is testingSafety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWho this might be right forAdvanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more NKGen Biotech, Inc.
Testing effectiveness (Phase 2)Study completedNCT03409848What this trial is testingIpilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaWho this might be right forGastric CancerEsophageal CancerAdenocarcinoma Gastric+3 more AIO-Studien-gGmbH 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT03641313What this trial is testingBerzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction CancerWho this might be right forClinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+5 more National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT01716546What this trial is testingTrial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric CancerWho this might be right forGastric Cancer Hellenic Oncology Research Group 51
Large-scale testing (Phase 3)Looking for participantsNCT07431281What this trial is testingSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Who this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaEsophageal Cancer AstraZeneca 2,130
Testing effectiveness (Phase 2)Study completedNCT04014075What this trial is testingDS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)Who this might be right forAdenocarcinoma Gastric Stage IV With MetastasesAdenocarcinoma - GEJ Daiichi Sankyo 79
Not applicableStudy completedNCT05035602What this trial is testingGoogle Location History Following Oesophagectomy and/or GastrectomyWho this might be right forOesophageal CancerGastric CancerSurvivorship+1 more Imperial College London 3